ID   FOXO1_RAT               Reviewed;         649 AA.
AC   G3V7R4;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 1.
DT   29-MAY-2024, entry version 94.
DE   RecName: Full=Forkhead box protein O1;
DE   AltName: Full=Forkhead box protein O1A;
DE   AltName: Full=Forkhead in rhabdomyosarcoma;
GN   Name=Foxo1; Synonyms=Foxo1a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE,
RP   INDUCTION BY BLOOD FLOW CESSATION INJURY, AND PHOSPHORYLATION AT SER-250.
RX   PubMed=19483080; DOI=10.1074/jbc.m109.017046;
RA   Li F., Xie P., Fan Y., Zhang H., Zheng L., Gu D., Patterson C., Li H.;
RT   "C terminus of Hsc70-interacting protein promotes smooth muscle cell
RT   proliferation and survival through ubiquitin-mediated degradation of
RT   FoxO1.";
RL   J. Biol. Chem. 284:20090-20098(2009).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-281 AND SER-323, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   FUNCTION.
RX   PubMed=26436652; DOI=10.1172/jci82423;
RA   Huang Z.P., Kataoka M., Chen J., Wu G., Ding J., Nie M., Lin Z., Liu J.,
RA   Hu X., Ma L., Zhou B., Wakimoto H., Zeng C., Kyselovic J., Deng Z.L.,
RA   Seidman C.E., Seidman J.G., Pu W.T., Wang D.Z.;
RT   "Cardiomyocyte-enriched protein CIP protects against pathophysiological
RT   stresses and regulates cardiac homeostasis.";
RL   J. Clin. Invest. 125:4122-4134(2015).
CC   -!- FUNCTION: Transcription factor that is the main target of insulin
CC       signaling and regulates metabolic homeostasis in response to oxidative
CC       stress (By similarity). Binds to the insulin response element (IRE)
CC       with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16
CC       family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-
CC       3'. Activity suppressed by insulin (By similarity). Main regulator of
CC       redox balance and osteoblast numbers and controls bone mass (By
CC       similarity). Orchestrates the endocrine function of the skeleton in
CC       regulating glucose metabolism (By similarity). Also acts as a key
CC       regulator of chondrogenic commitment of skeletal progenitor cells in
CC       response to lipid availability: when lipids levels are low,
CC       translocates to the nucleus and promotes expression of SOX9, which
CC       induces chondrogenic commitment and suppresses fatty acid oxidation (By
CC       similarity). Acts synergistically with ATF4 to suppress
CC       osteocalcin/BGLAP activity, increasing glucose levels and triggering
CC       glucose intolerance and insulin insensitivity (By similarity). Also
CC       suppresses the transcriptional activity of RUNX2, an upstream activator
CC       of osteocalcin/BGLAP (By similarity). Acts as an inhibitor of glucose
CC       sensing in pancreatic beta cells by acting as a transcription repressor
CC       and suppressing expression of PDX1 (By similarity). In hepatocytes,
CC       promotes gluconeogenesis by acting together with PPARGC1A and CEBPA to
CC       activate the expression of genes such as IGFBP1, G6PC1 and PCK1 (By
CC       similarity). Also promotes gluconeogenesis by directly promoting
CC       expression of PPARGC1A and G6PC1 (By similarity). Important regulator
CC       of cell death acting downstream of CDK1, PKB/AKT1 and STK4/MST1 (By
CC       similarity). Promotes neural cell death (By similarity). Mediates
CC       insulin action on adipose tissue (By similarity). Regulates the
CC       expression of adipogenic genes such as PPARG during preadipocyte
CC       differentiation and, adipocyte size and adipose tissue-specific gene
CC       expression in response to excessive calorie intake (By similarity).
CC       Regulates the transcriptional activity of GADD45A and repair of nitric
CC       oxide-damaged DNA in beta-cells (By similarity). Required for the
CC       autophagic cell death induction in response to starvation or oxidative
CC       stress in a transcription-independent manner (By similarity). Mediates
CC       the function of MLIP in cardiomyocytes hypertrophy and cardiac
CC       remodeling (PubMed:26436652). Positive regulator of apoptosis in
CC       cardiac smooth muscle cells as a result of its transcriptional
CC       activation of pro-apoptotic genes (PubMed:19483080). Regulates
CC       endothelial cell (EC) viability and apoptosis in a PPIA/CYPA-dependent
CC       manner via transcription of CCL2 and BCL2L11 which are involved in EC
CC       chemotaxis and apoptosis (By similarity).
CC       {ECO:0000250|UniProtKB:Q12778, ECO:0000250|UniProtKB:Q9R1E0,
CC       ECO:0000269|PubMed:19483080, ECO:0000269|PubMed:26436652}.
CC   -!- SUBUNIT: Interacts with LRPPRC. Interacts with RUNX2; the interaction
CC       inhibits RUNX2 transcriptional activity and mediates the IGF1/insulin-
CC       dependent BGLAP expression in osteoblasts Interacts with PPP2R1A; the
CC       interaction regulates the dephosphorylation of FOXO1 at Thr-24 and Ser-
CC       250 leading to its nuclear import. Interacts with NLK. Interacts with
CC       SIRT1; the interaction results in the deacetylation of FOXO1 leading to
CC       activation of FOXO1-mediated transcription of genes involved in DNA
CC       repair and stress resistance. Binds to CDK1. Interacts with the 14-3-3
CC       proteins, YWHAG and YWHAZ; the interactions require insulin-stimulated
CC       phosphorylation on Thr-24, promote nuclear exit and loss of
CC       transcriptional activity. Interacts with SKP2; the interaction
CC       ubiquitinates FOXO1 leading to its proteasomal degradation. The
CC       interaction requires the presence of KRIT1. Interacts (via the C-
CC       terminal half) with ATF4 (via its DNA binding domain); the interaction
CC       occurs in osteoblasts, regulates glucose homeostasis via suppression of
CC       beta-cell proliferation and subsequent decrease in insulin production.
CC       Interacts with PRMT1; the interaction methylates FOXO1, prevents
CC       PKB/AKT1 phosphorylation and retains FOXO1 in the nucleus. Interacts
CC       with EP300 and CREBBP; the interactions acetylate FOXO1. Interacts with
CC       SIRT2; the interaction is disrupted in response to oxidative stress or
CC       serum deprivation, leading to increased level of acetylated FOXO1,
CC       which promotes stress-induced autophagy by stimulating E1-like
CC       activating enzyme ATG7. Interacts (acetylated form) with ATG7; the
CC       interaction is increased in response to oxidative stress or serum
CC       deprivation and promotes the autophagic process leading to cell death.
CC       Interacts (acetylated form) with PPARG. Interacts with XBP1; this
CC       interaction is direct and leads to FOXO1 ubiquitination and degradation
CC       via the proteasome pathway (By similarity). Interacts (via the Fork-
CC       head domain) with CEBPA; the interaction increases when FOXO1 is
CC       deacetylated. Interacts with WDFY2. Forms a complex with WDFY2 and AKT1
CC       (By similarity). Interacts with CRY1 (By similarity). Interacts with
CC       PPIA/CYPA; the interaction promotes FOXO1 dephosphorylation, nuclear
CC       accumulation and transcriptional activity (By similarity). Interacts
CC       with TOX4; FOXO1 is required for full induction of TOX4-dependent
CC       activity and the interaction is inhibited by insulin (By similarity).
CC       Interacts (when phosphorylated on Ser-250) with STUB1/CHIP (By
CC       similarity). {ECO:0000250|UniProtKB:Q12778,
CC       ECO:0000250|UniProtKB:Q9R1E0}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19483080}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9R1E0}. Note=Shuttles between the cytoplasm and
CC       nucleus (By similarity). Largely nuclear in unstimulated cells (By
CC       similarity). In osteoblasts, colocalizes with ATF4 and RUNX2 in the
CC       nucleus. Serum deprivation increases localization to the nucleus,
CC       leading to activate expression of SOX9 and subsequent chondrogenesis
CC       (By similarity). Insulin-induced phosphorylation at Ser-253 by PKB/AKT1
CC       leads, via stimulation of Thr-24 phosphorylation, to binding of 14-3-3
CC       proteins and nuclear export to the cytoplasm where it is degraded by
CC       the ubiquitin-proteasomal pathway (By similarity). Phosphorylation at
CC       Ser-249 by CDK1 disrupts binding of 14-3-3 proteins and promotes
CC       nuclear accumulation (By similarity). Phosphorylation by NLK results in
CC       nuclear export (By similarity). Translocates to the nucleus upon
CC       oxidative stress-induced phosphorylation at Ser-212 by STK4/MST1 (By
CC       similarity). SGK1-mediated phosphorylation also results in nuclear
CC       translocation. Retained in the nucleus under stress stimuli including
CC       oxidative stress, nutrient deprivation or nitric oxide. Methylated form
CC       is nuclear (By similarity). PPIA/CYPA stimulates its nuclear
CC       accumulation (By similarity). Deacetylation by SIRT6, promotes its
CC       translocation into the cytoplasm (By similarity).
CC       {ECO:0000250|UniProtKB:Q12778, ECO:0000250|UniProtKB:Q9R1E0}.
CC   -!- TISSUE SPECIFICITY: Expressed in the internal elastic lamina of the
CC       carotid artery (at protein level). {ECO:0000269|PubMed:19483080}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in neonatal cardiomyocytes (at protein
CC       level). {ECO:0000269|PubMed:19483080}.
CC   -!- INDUCTION: Down-regulated in the neointimal layer of the carotid artery
CC       by blood flow cessation injury. {ECO:0000269|PubMed:19483080}.
CC   -!- PTM: Phosphorylation by NLK promotes nuclear export and inhibits the
CC       transcriptional activity. In response to growth factors,
CC       phosphorylation on Thr-24, Ser-250 and Ser-313 by PKB/AKT1 promotes
CC       nuclear export and inactivation of transactivational activity
CC       (PubMed:19483080). Phosphorylation on Thr-24 is required for binding
CC       14-3-3 proteins. Phosphorylation of Ser-250 decreases DNA-binding
CC       activity and promotes the phosphorylation of Thr-24 and Ser-313,
CC       permitting phosphorylation of Ser-316 and Ser-319, probably by CDK1,
CC       leading to nuclear exclusion and loss of function. Stress signals, such
CC       as response to oxygen or nitric oxide, attenuate the PKB/AKT1-mediated
CC       phosphorylation leading to nuclear retention. Phosphorylation of Ser-
CC       323 is independent of IGF1 and leads to reduced function.
CC       Dephosphorylated on Thr-24 and Ser-250 by PP2A in beta-cells under
CC       oxidative stress leading to nuclear retention. Phosphorylation of Ser-
CC       243 by CDK1 disrupts binding of 14-3-3 proteins leading to nuclear
CC       accumulation and has no effect on DNA binding nor transcriptional
CC       activity. Phosphorylation by STK4/MST1 on Ser-206, upon oxidative
CC       stress, inhibits binding to 14-3-3 proteins and nuclear export (By
CC       similarity). PPIA/CYPA promotes its dephosphorylation on Ser-250 (By
CC       similarity). {ECO:0000250|UniProtKB:Q12778,
CC       ECO:0000250|UniProtKB:Q9R1E0, ECO:0000269|PubMed:19483080}.
CC   -!- PTM: Ubiquitinated by SKP2 (By similarity). Ubiquitination leads to
CC       proteasomal degradation (By similarity). Ubiquitinated by STUB1/CHIP;
CC       when Ser-250 is phosphorylated (By similarity).
CC       {ECO:0000250|UniProtKB:Q12778, ECO:0000250|UniProtKB:Q9R1E0}.
CC   -!- PTM: Methylation inhibits AKT1-mediated phosphorylation at Ser-250 and
CC       is increased by oxidative stress. {ECO:0000250|UniProtKB:Q9R1E0}.
CC   -!- PTM: Acetylated. Acetylation at Lys-256 and Lys-268 are necessary for
CC       autophagic cell death induction. Deacetylated by SIRT2 in response to
CC       oxidative stress or serum deprivation, thereby negatively regulating
CC       FOXO1-mediated autophagic cell death. Once in the nucleus, acetylated
CC       by CREBBP/EP300. Acetylation diminishes the interaction with target DNA
CC       and attenuates the transcriptional activity. It increases the
CC       phosphorylation at Ser-250. Deacetylation by SIRT1 results in
CC       reactivation of the transcriptional activity. Oxidative stress by
CC       hydrogen peroxide treatment appears to promote deacetylation and
CC       uncoupling of insulin-induced phosphorylation. By contrast, resveratrol
CC       acts independently of acetylation. Acetylated at Lys-417, promoting its
CC       localization to the nucleus and transcription factor activity.
CC       Deacetylation at Lys-417 by SIRT6, promotes its translocation into the
CC       cytoplasm, preventing its transcription factor activity. Deacetylation
CC       and subsequent inhibition by SIRT6 has different effects depending on
CC       cell types: it inhibits gluconeogenesis in hepatocytes, promotes
CC       glucose sensing in pancreatic beta-cells and regulates lipid catabolism
CC       in brown adipocytes. {ECO:0000250|UniProtKB:Q12778}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH474003; EDM14970.1; -; Genomic_DNA.
DR   RefSeq; NP_001178775.1; NM_001191846.2.
DR   AlphaFoldDB; G3V7R4; -.
DR   SMR; G3V7R4; -.
DR   BioGRID; 249982; 3.
DR   STRING; 10116.ENSRNOP00000018244; -.
DR   GlyGen; G3V7R4; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; G3V7R4; -.
DR   PhosphoSitePlus; G3V7R4; -.
DR   PaxDb; 10116-ENSRNOP00000018244; -.
DR   Ensembl; ENSRNOT00000018244.6; ENSRNOP00000018244.3; ENSRNOG00000013397.6.
DR   Ensembl; ENSRNOT00055040966; ENSRNOP00055033296; ENSRNOG00055023877.
DR   Ensembl; ENSRNOT00060000991; ENSRNOP00060000313; ENSRNOG00060000806.
DR   Ensembl; ENSRNOT00065045184; ENSRNOP00065037059; ENSRNOG00065026196.
DR   GeneID; 84482; -.
DR   KEGG; rno:84482; -.
DR   AGR; RGD:620283; -.
DR   CTD; 2308; -.
DR   RGD; 620283; Foxo1.
DR   eggNOG; KOG2294; Eukaryota.
DR   GeneTree; ENSGT00940000161558; -.
DR   HOGENOM; CLU_023456_1_1_1; -.
DR   InParanoid; G3V7R4; -.
DR   OMA; KMMSPSS; -.
DR   OrthoDB; 5385885at2759; -.
DR   TreeFam; TF315583; -.
DR   Reactome; R-RNO-198693; AKT phosphorylates targets in the nucleus.
DR   Reactome; R-RNO-211163; AKT-mediated inactivation of FOXO1A.
DR   Reactome; R-RNO-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-RNO-9614399; Regulation of localization of FOXO transcription factors.
DR   Reactome; R-RNO-9617629; Regulation of FOXO transcriptional activity by acetylation.
DR   Reactome; R-RNO-9617828; FOXO-mediated transcription of cell cycle genes.
DR   PRO; PR:G3V7R4; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Proteomes; UP000234681; Chromosome 2.
DR   Bgee; ENSRNOG00000013397; Expressed in ovary and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0008013; F:beta-catenin binding; ISO:RGD.
DR   GO; GO:0031490; F:chromatin DNA binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0003676; F:nucleic acid binding; ISO:RGD.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISO:RGD.
DR   GO; GO:0051721; F:protein phosphatase 2A binding; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0001223; F:transcription coactivator binding; IPI:RGD.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:RGD.
DR   GO; GO:0006915; P:apoptotic process; ISS:UniProtKB.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0001568; P:blood vessel development; ISO:RGD.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0030154; P:cell differentiation; IEA:UniProtKB-KW.
DR   GO; GO:0071549; P:cellular response to dexamethasone stimulus; IEP:RGD.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0071455; P:cellular response to hyperoxia; ISS:UniProtKB.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:UniProtKB.
DR   GO; GO:0071732; P:cellular response to nitric oxide; ISS:UniProtKB.
DR   GO; GO:0034599; P:cellular response to oxidative stress; ISS:UniProtKB.
DR   GO; GO:0009267; P:cellular response to starvation; ISS:UniProtKB.
DR   GO; GO:0006974; P:DNA damage response; ISS:UniProtKB.
DR   GO; GO:0070166; P:enamel mineralization; IEP:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:1903243; P:negative regulation of cardiac muscle hypertrophy in response to stress; IMP:UniProtKB.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; ISS:UniProtKB.
DR   GO; GO:0032873; P:negative regulation of stress-activated MAPK cascade; ISO:RGD.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; ISO:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0010508; P:positive regulation of autophagy; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0045722; P:positive regulation of gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:0045732; P:positive regulation of protein catabolic process; ISS:UniProtKB.
DR   GO; GO:0034393; P:positive regulation of smooth muscle cell apoptotic process; IMP:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0006111; P:regulation of gluconeogenesis; ISO:RGD.
DR   GO; GO:2000177; P:regulation of neural precursor cell proliferation; ISO:RGD.
DR   GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:RGD.
DR   GO; GO:0060260; P:regulation of transcription initiation by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0070542; P:response to fatty acid; ISS:UniProtKB.
DR   GO; GO:1902617; P:response to fluoride; IEP:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   CDD; cd20060; FH_FOXO1; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR047408; FH_FOXO1.
DR   InterPro; IPR001766; Fork_head_dom.
DR   InterPro; IPR032067; FOXO-TAD.
DR   InterPro; IPR032068; FOXO_KIX-bd.
DR   InterPro; IPR030456; TF_fork_head_CS_2.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR45767; FORKHEAD BOX PROTEIN O; 1.
DR   PANTHER; PTHR45767:SF1; FORKHEAD BOX PROTEIN O1; 1.
DR   Pfam; PF00250; Forkhead; 1.
DR   Pfam; PF16676; FOXO-TAD; 1.
DR   Pfam; PF16675; FOXO_KIX_bdg; 1.
DR   PRINTS; PR00053; FORKHEAD.
DR   SMART; SM00339; FH; 1.
DR   SUPFAM; SSF46785; Winged helix' DNA-binding domain; 1.
DR   PROSITE; PS00658; FORK_HEAD_2; 1.
DR   PROSITE; PS50039; FORK_HEAD_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Apoptosis; Autophagy; Cytoplasm; Differentiation;
KW   DNA-binding; Methylation; Nucleus; Phosphoprotein; Reference proteome;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..649
FT                   /note="Forkhead box protein O1"
FT                   /id="PRO_0000419245"
FT   DNA_BIND        154..248
FT                   /note="Fork-head"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00089"
FT   REGION          1..62
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          112..151
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          205..212
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   REGION          228..339
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          228..231
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   REGION          277..557
FT                   /note="Sufficient for interaction with NLK"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E0"
FT   REGION          357..453
FT                   /note="Required for interaction with RUNX2"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E0"
FT   MOTIF           245..247
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOTIF           456..460
FT                   /note="Required for interaction with SIRT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E0"
FT   COMPBIAS        27..62
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        113..137
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        274..324
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            152
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   SITE            159
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   SITE            219
FT                   /note="DNA-binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         24
FT                   /note="Phosphothreonine; by PKB/AKT1 or PKB/AKT2 and SGK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         206
FT                   /note="Phosphoserine; by STK4/MST1"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         212
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         228
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         239
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E0"
FT   MOD_RES         242
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E0"
FT   MOD_RES         243
FT                   /note="Phosphoserine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         245
FT                   /note="Omega-N-methylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E0"
FT   MOD_RES         247
FT                   /note="Omega-N-methylarginine; by PRMT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E0"
FT   MOD_RES         250
FT                   /note="Phosphoserine; by PKB/AKT1 and SGK1"
FT                   /evidence="ECO:0000269|PubMed:19483080"
FT   MOD_RES         256
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         259
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         268
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         281
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         292
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E0"
FT   MOD_RES         313
FT                   /note="Phosphoserine; by PKB/AKT1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E0"
FT   MOD_RES         316
FT                   /note="Phosphoserine; by CK1 and SGK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         319
FT                   /note="Phosphoserine; by CK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
FT   MOD_RES         323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         327
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E0"
FT   MOD_RES         417
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q12778"
SQ   SEQUENCE   649 AA;  69344 MW;  6232AA82C12F5AEA CRC64;
     MAEAPQVVET DPDFEPLPRQ RSCTWPLPRP EFNQSNSTTS SPAPSGSTAA NPDATASLAS
     ASAVSTDFMS NLSLLEESED FARAPGCVAV AAAAAASRGL CGDFQGPEAG CVHSAPPQPP
     PTGPLSQPPP VPPAAAGPLA GQPRKTSSSR RNAWGNLSYA DLITKAIESS AEKRLTLSQI
     YEWMVKSVPY FKDKGDSNSS AGWKNSIRHN LSLHSKFIRV QNEGTGKSSW WMLNPEGGKS
     GKSPRRRAAS MDNNSKFAKS RGRAAKKKAS LQSGQEGPGD SPGSQFSKWP ASPGSHSNDD
     FDNWSTFRPR TSSNASTISG RLSPIMTEQD DLGDGDVHSL VYPPSAAKMA STLPSLSEIS
     NPENMENLLD NLNLLSSPTS LTVSTQSSPG SMMQQTPCYS FAPPNTSLNS PSPNYAKYTY
     GQSSMSPVPQ MPMQTLQDSK SSYGGLNQYN CAPGLLKELL TSDSPPHNDI MSPVDPGVAQ
     PNSRVLGQNV LMGPNSVMPA YGSQAPHNKM MNPSSHTHPG HAQQTSSVNG RALPHVVNTM
     PHTSAMNRLT PVKTPLQVPL SHPMQMSALG NYSSVSSCNG YGRMGVLHQE KLPSDLDGMF
     IERLDCDMES IIRNDLMDGD TLDFNFDNVL PNQSFPHSVK TTTHSWVSG
//
